Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #8190
Reference
MSAN(2024)37
Name
Humalog® (insulin lispro) 100units/ml solution for injection 10ml vials
Categories
Scottish Government
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
Scotland
Health Boards
Pharmaceutical Services
Supplies
Drug Shortages
Description
Humalog® (insulin lispro) 100units/ml 10ml vials will be out of stock from early June 2024 until early July 2024.
NovoRapid® and Trurapi® (insulin aspart) 100units/ml 10ml vials remain available.
Admelog® and Lyumjev® (insulin lispro) 100units/ml 10ml vials remain available, however cannot support an increase in demand.
Fiasp® (insulin aspart) 100units/ml 10ml vials remain available, however cannot support an increase in demand.
Humalog® 100units/ml 3ml cartridges and Humalog KwikPen® and Junior KwikPen® 100 units/ml 3ml pre-filled pens remain available and can support increased demand.
This MSAN is the one of two covering supply issues with insulin vials. MSAN(2024)26 issued on 20/05/24 covered Humulin® S (insulin soluble human). This MSAN, MSAN(2024)37, covers Humalog® (insulin lispro). As these products have similar sounding names, appropriate risk minimisation strategies should be implemented to ensure actions are carried out for specific products.
Contact Name
Contact Email
Contact Address
Created
2024-06-21 09:18:00
Click to go back to homepage